MediPharm Labs Corp (FRA:MLZ)
€ 0.0352 0 (0%) Market Cap: 16.45 Mil Enterprise Value: 8.16 Mil PE Ratio: 0 PB Ratio: 0.55 GF Score: 0/100

Q2 2023 Medipharm Labs Corp Earnings Call Transcript

Aug 14, 2023 / 12:30PM GMT
Release Date Price: €0.0461 (-8.35%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the MediPharm Labs' 2023 second-quarter financial results conference call. Please be advised that today's conference is being recorded. Before we begin, please note that remarks today may contain forward-looking information and forward-looking statements within the meaning of applicable securities laws. This includes, without limitation, statements about MediPharm Labs and its current and future plans, expectations, intentions, financial results, levels of activity, performance, goals or achievements, and other future events, trends or developments, statements about MediPharm's acquisition of VIVO Cannabis Incorporated, the combined company's future financial and operational performance, the combined company's key business segments, product offerings, pro forma, and overall financial performance, potential revenue and cost synergies resulting from the transaction and statements about combined company's profitability and ability to grow the business going forward.

Forward-looking statements are made as of the date hereof based on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot